Editorial: The Non-coding Genome and Cardiovascular Disease

Paras Kumar Mishra^{1

2}, Georges Nemer³

Affiliations

¹ Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE, United States.
² Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE, United States.
³ Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon.

Editorial

Paras Kumar Mishra et al. Front Cardiovasc Med. 2019.

. 2019 Jul 16:6:98.

doi: 10.3389/fcvm.2019.00098. eCollection 2019.

Paras Kumar Mishra^{1

2}, Georges Nemer³

¹ Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE, United States.
² Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE, United States.
³ Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon.

No abstract available

Keywords: cardiomyopathies; diabetes; genetic mutation analysis; heart; lncRNA; miRNA.

Comment on

Editorial on the Research Topic The Non-coding Genome and Cardiovascular Disease

1. Lander ES. Initial impact of the sequencing of the human genome. Nature. (2011) 470:187–97. 10.1038/nature09792 - DOI - PubMed
1. Fernandes JCR, Acuna SM, Aoki JI, Floeter-Winter LM, Muxel SM. Long non-coding RNAs in the regulation of gene expression: physiology and disease. Noncoding RNA. (2019) 5:17. 10.3390/ncrna5010017 - DOI - PMC - PubMed
1. Bartel DP, Chen CZ. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet. (2004) 5:396–400. 10.1038/nrg1328 - DOI - PubMed
1. Duenas A, Exposito A, Aranega A, Franco D. The role of non-coding RNA in congenital heart diseases. J Cardiovasc Dev Dis. (2019) 6:E15. 10.3390/jcdd6020015 - DOI - PMC - PubMed
1. Mishra PK, Tyagi N, Kumar M, Tyagi SC. MicroRNAs as a therapeutic target for cardiovascular diseases. J Cell Mol Med. (2009) 13:778–89. 10.1111/j.1582-4934.2009.00744.x - DOI - PMC - PubMed